Use of vaccines for the treatment/ prevention of the transmission of influenza pathogens between species

Details for Australian Patent Application No. 2006309007 (hide)

Owner Boehringer Ingelheim Vetmedica GmbH

Inventors Vaughn, Eric Martin; Daemmgen, Juergen

Agent Davies Collison Cave

Pub. Number AU-A-2006309007

PCT Pub. Number WO2007/053446

Priority 60/730,998 28.10.05 US

Filing date 27 October 2006

Wipo publication date 10 May 2007

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

Event Publications

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/053446 Priority application(s): WO2007/053446

19 June 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Boehringer Ingelheim Vetmedica GmbH, Application No. 2006309007, under INID (71), correct the name to read Boehringer Ingelheim Vetmedica, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006309008-Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions

2006308991-Chemical preconditioning as a preventative or treatment for excitotoxic synaptic damage